These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17127488)
41. Glycoprotein IbĪ± clustering induces macrophage-mediated platelet clearance in the liver. Yan R; Chen M; Ma N; Zhao L; Cao L; Zhang Y; Zhang J; Yu Z; Wang Z; Xia L; Ruan C; Dai K Thromb Haemost; 2015 Jan; 113(1):107-17. PubMed ID: 25231551 [TBL] [Abstract][Full Text] [Related]
42. [Identification of human platelet specific functional antibody and its fragments]. Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061 [TBL] [Abstract][Full Text] [Related]
43. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody. Shao L; Wu Y; Zhou H; Qin P; Ni H; Peng J; Hou M Platelets; 2015; 26(5):495-7. PubMed ID: 25166956 [TBL] [Abstract][Full Text] [Related]
44. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies. Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587 [TBL] [Abstract][Full Text] [Related]
45. [Epitope analysis of anti-GPIIb-IIIa autoantibodies in chronic ITP]. Kosugi S; Tomiyama Y Rinsho Ketsueki; 2005 Feb; 46(2):104-8. PubMed ID: 16447703 [No Abstract] [Full Text] [Related]
46. Identification of an epitope on glycoprotein IIb-IIIa that is recognized by HLA-DRB1*0405-restricted CD4+'superior' T cells from a patient with immune thrombocytopenic purpura. Yamanouchi J; Hato T; Tamura T; Fujita S; Yasukawa M J Thromb Haemost; 2004 Feb; 2(2):348-50. PubMed ID: 14996009 [No Abstract] [Full Text] [Related]
47. Rifampicin-dependent antibodies target glycoprotein IIb/IIIa and cause clearance of human platelets in NOD/SCID mice. Sun P; Wu G; Gao RL; Liu S; Phillips WD; Liang SX Br J Haematol; 2016 Jan; 172(1):137-40. PubMed ID: 25921553 [No Abstract] [Full Text] [Related]
48. Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia. Arnold DM; Santoso S; Greinacher A; J Thromb Haemost; 2012 Apr; 10(4):695-7. PubMed ID: 22332994 [No Abstract] [Full Text] [Related]
49. Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura. Ozsoylu S Am J Hematol; 1996 Apr; 51(4):328. PubMed ID: 8602636 [No Abstract] [Full Text] [Related]
50. Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen. Bougie D; Aster R Blood; 2001 Jun; 97(12):3846-50. PubMed ID: 11389025 [TBL] [Abstract][Full Text] [Related]
51. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer. O'Brien JR; Etherington MD Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994 [TBL] [Abstract][Full Text] [Related]
52. Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia. Tao L; Zeng Q; Li J; Xu M; Wang J; Pan Y; Wang H; Tao Q; Chen Y; Peng J; Hou M; Jansen AJ; Ni H; Zhai Z J Hematol Oncol; 2017 Feb; 10(1):46. PubMed ID: 28179000 [TBL] [Abstract][Full Text] [Related]
53. [Significance of detection of anti-GPIIb/IIIa antibody secreting B cells and platelet-specific antibody in patients with idiopathic thrombocytopenic purpura]. Chen JF; Yang LH; Dong CX; Feng JJ; Liu XE; Lu YJ; Chang LX; Liu JQ Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):603-6. PubMed ID: 21122320 [TBL] [Abstract][Full Text] [Related]
54. Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial. Li MF; Li XL; Fan KL; Yu YY; Gong J; Geng SY; Liang YF; Huang L; Qiu JH; Tian XH; Wang WT; Zhang XL; Yu QX; Zhang YF; Lin P; Wang LN; Li X; Hou M; Liu LY; Peng J J Hematol Oncol; 2017 May; 10(1):104. PubMed ID: 28494777 [TBL] [Abstract][Full Text] [Related]
56. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events. Dunkley S; Evans S; Gaudry L; Jepson N Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613 [TBL] [Abstract][Full Text] [Related]
58. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells. Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244 [TBL] [Abstract][Full Text] [Related]
59. Quantitative comparisons of antibody-binding sites of platelet glycoprotein IIb/IIIa in aplastic anemia and idiopathic thrombocytopenic purpura. Kahng J; Park HH; Han K; Choi BY; Lee W Ann Clin Lab Sci; 2008; 38(1):6-11. PubMed ID: 18316775 [TBL] [Abstract][Full Text] [Related]